Related Experiment Video
Updated: Dec 26, 2025
06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
7.9K
Prostate Cancer Brain Metastases: A Single-Institution Experience
Hriday P Bhambhvani1, Daniel R Greenberg2, Sandy Srinivas3
1Department of Neurosurgery, Stanford University Medical Center, Stanford, California, USA.
World Neurosurgery
|March 10, 2020
Summary
Brain metastases from prostate cancer are rare, accounting for 0.86% of all brain metastases. Treatment improves survival, but prognosis remains poor in advanced, castrate-resistant disease.
Area of Science:
- Oncology
- Neurology
- Cancer Metastasis
Background:
- Brain metastases from prostate cancer are infrequently documented.
- Understanding their clinical characteristics and outcomes is crucial.
Purpose of the Study:
- To determine the incidence of prostate cancer brain metastases.
- To describe their clinical features, treatments, and survival.
- To inform patient counseling.
Main Methods:
- Retrospective review of 31 patients with prostate adenocarcinoma brain metastases.
- Data collected from 2008 to 2018.
- Analysis of clinical characteristics, treatments, and survival outcomes.
Main Results:
- Prostate cancer accounted for 0.86% of brain metastases.
- Median survival was 3 months, significantly increased with radiosurgery (4.6 months) or surgery plus radiotherapy (13 months).
- Patients often had concurrent bone, lung, and liver metastases.
Conclusions:
- Prostate cancer brain metastases are rare but indicate advanced, castrate-resistant disease with poor prognosis.
- Treatment can prolong survival, but outcomes remain challenging.
- Physicians can use these findings for better patient counseling.
